Researchers characterized more than 800 breast tumors using whole-exome sequencing, RNA sequencing, miRNA sequencing, and other methods.
In Nature this week: genomic analysis of 200 bird species, and more.
A team of scientists believe that exosomal miRNAs holds promise to be significant biomarkers for Alzheimer's disease.
The company aims to validate two diagnostic algorithms based in part on microRNA biomarkers to identify patients with moderate-to-severe disease.
The findings reveal a new layer of complexity around the role of microRNAs and highlight how race can influence their role in cancer and potentially other diseases.
NIH researchers have uncovered a blood-based microRNA signature that may be able to tell which patients with precursor disease may progress to myeloma.
Under the arrangement, Rosetta would offer physicians the option to have thyroid samples analyzed by FNApath, with indeterminate samples tested with its microRNA assay.
CBC also recently achieved ISO DIN/EN 17025:2005 accreditation for the extraction of total RNA from body fluids and the analysis of microRNA and mRNA.
The researchers are following up on earlier NIH-funded work examining microRNAs as potential indicators of clinical outcomes of heart disease patients.
In PNAS this week: genetic variation, environmental factors influence infants' attention to emotion, role for miR-150 in maintaining normal retinal blood vessel repertoires, and more.
At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.
The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.
Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.
In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.